Deerfield Special Situations Fund, L.P., 10% Owner at Vanda Pharmaceuticals Inc. (VNDA), bought 425,982 shares at $8.61 ($3.7M) on 2015-12-11, disclosed to the SEC on 2015-12-18.
Open-market purchase of $3.7M VNDA by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.59 | 29,902 | $257K | 7.0% |
| 2 | $8.59 | 32,211 | $277K | 7.5% |
| 3 | $8.59 | 40,997 | $352K | 9.6% |
| 4 | $8.61 | 93,634 | $806K | 22.0% |
| 5 | $8.61 | 100,864 | $868K | 23.7% |
| 6 | $8.61 | 128,374 |
| $1.1M |
| 30.2% |
| Total | $8.61 avg | 425,982 | $3.7M | 100% |
| Filing → |
| VNDA | BUY | 2015-12-11 | $6.4M | — | Filing → |
| ALIM | BUY | 2015-12-08 | $494K | — | Filing → |
| ALIM | BUY | 2015-10-21 | $580K | — | Filing → |